Neo Ivy Capital Management Acquires Stake in American Healthcare REIT
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 13 2026
0mins
Should l Buy AHR?
Source: NASDAQ.COM
- Share Acquisition: Neo Ivy Capital Management disclosed in its February 13, 2026 SEC filing that it acquired 136,925 shares of American Healthcare REIT for an estimated $6.44 million, representing 1.02% of the fund's AUM, which does not place it among the top five holdings.
- Financial Performance: American Healthcare REIT reported a 16.4% same-store NOI growth in Q3, driven by a 25.3% increase in senior housing operating properties and a 21.7% rise in integrated senior health campuses, indicating robust market demand.
- Profitability Improvement: The company achieved a GAAP net income of $55.9 million, translating to $0.33 per diluted share, while normalized FFO stood at $0.44 per share; management raised the full-year NFFO guidance to a range of $1.69 to $1.72, reflecting confidence in future performance.
- Market Outlook: Although Neo Ivy's stake is modest at 1.02%, the ongoing demand in healthcare real estate and expectations of sustained occupancy rates above 90% suggest potential growth for long-term investors, particularly with disciplined capital allocation strategies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AHR
Wall Street analysts forecast AHR stock price to rise
12 Analyst Rating
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 52.240
Low
47.00
Averages
55.25
High
60.00
Current: 52.240
Low
47.00
Averages
55.25
High
60.00
About AHR
American Healthcare REIT, Inc. is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing, skilled nursing facilities, outpatient medical (OM) buildings and other healthcare-related facilities across the United States, the United Kingdom and the Isle of Man. It owns and operates its integrated senior health campuses and senior housing operating properties (SHOP). Its segments include integrated senior health campuses, OM, SHOP and triple-net leased properties. Its OM buildings are leased to multiple tenants under separate leases. Its integrated senior health campuses each provide a range of independent living, assisted living, memory care, skilled nursing services and ancillary businesses. Its triple-net leased properties segment includes senior housing, skilled nursing facilities and hospitals. Its SHOP segment includes senior housing providing assisted living care, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
American Healthcare REIT Q4 2025 Earnings Call Insights
- Leadership Transition: Chairman and Interim CEO Jeffrey Hanson confirmed during the earnings call that despite the CEO's medical leave, the company's strategic direction and execution remain unchanged, ensuring investor confidence in future performance.
- Strong Financial Performance: In Q4 2025, AHR reported same-store NOI growth of 11.8% and 14.2% for the full year, demonstrating robust performance particularly in the Trilogy and SHOP segments, which further solidifies its market position.
- Active Investment Activity: The company closed over $950 million in new investments across its Trilogy and SHOP segments, with a focus on adding assets in attractive submarkets within SHOP, enhancing cash flow and portfolio diversification.
- Optimistic Outlook: Management issued 2026 NFFO guidance of $1.99 to $2.05 per diluted share, implying continued double-digit growth, while same-store NOI growth is expected to range between 7% and 11%, reflecting confidence in future growth prospects.
See More
American Healthcare REIT (AHR) Earnings Call
See More
American Healthcare REIT Issues 2026 Guidance Amid Q4 Results
- Financial Overview: American Healthcare REIT (AHR) reported Q4 FFO of $0.46, meeting expectations, while revenue of $604.08 million, up 11.3% year-over-year, fell short by $13.41 million, indicating revenue growth challenges.
- 2026 Performance Guidance: The company projects a midpoint net income per diluted share of $0.78 for 2026, ranging from $0.75 to $0.81, a significant increase from $0.42 in 2025, reflecting optimism about future profitability.
- NAREIT FFO Expectations: AHR anticipates a midpoint NAREIT FFO per diluted share of $1.96 for 2026, with a range of $1.93 to $1.99, compared to $1.76 in 2025, indicating improvements in cash flow management.
- Segment Growth Projections: The company expects total portfolio same-store NOI growth of 9.0% in 2026, with senior housing (SHOP) projected to grow by 17.0%, highlighting strong performance in specific market segments that could drive future growth.
See More
American Healthcare REIT Reports Strong 2025 Performance and 2026 Guidance
- Same-Store NOI Growth: The company reported an 11.8% Same-Store NOI growth for Q4 2025, with the SHOP segment leading at 24.6%, reflecting strong demand and supply fundamentals in the long-term care sector, which is expected to drive future revenue growth.
- Significant Acquisition Activity: In 2025, the company completed over $950 million in acquisitions, including approximately $370 million in the ISHC segment and $590 million in the SHOP segment, enhancing its asset portfolio and competitive positioning in the market.
- Capital Market Performance: As of December 31, 2025, the company had total debt of $1.54 billion and liquidity of approximately $1.14 billion, demonstrating strong financial flexibility and ongoing capital raising capabilities to support future expansion plans.
- 2026 Performance Guidance: The company anticipates Same-Store NOI growth for 2026 to range between 7% and 11%, with the SHOP segment expected to grow between 15% and 19%, which will provide continued earnings growth and returns for shareholders.
See More
American Healthcare REIT Executives to Participate in Citi Global Property CEO Conference
- Executive Participation: American Healthcare REIT's CFO Brian S. Peay, COO Gabe M. Willhite, and VP of Investor Relations & Finance Alan Peterson will participate in the Citi 2026 Global Property CEO Conference on March 4, 2026, showcasing the company's leadership in the healthcare real estate sector.
- Conference Timing: The roundtable discussion is scheduled from 8:10 to 8:45 a.m. Eastern Time, expected to attract significant attention from investors and industry experts, thereby enhancing the company's visibility in the market.
- Webcast Availability: The conference will be available via live webcast, allowing participants to watch in real-time through the provided link, with a replay available for one year post-conference, ensuring widespread dissemination of information.
- Company Background: American Healthcare REIT focuses on acquiring, owning, and operating a diversified portfolio of clinical healthcare real estate, primarily including senior housing communities, skilled nursing facilities, and outpatient medical buildings across the U.S., U.K., and the Isle of Man, demonstrating its strong foundation in the healthcare real estate market.
See More
Neo Ivy Capital Management Acquires Stake in American Healthcare REIT
- New Investment Position: Neo Ivy Capital Management disclosed in its February 13, 2026 SEC filing that it acquired 136,925 shares of American Healthcare REIT for approximately $6.44 million during Q4, indicating a strategic entry into the healthcare real estate market.
- Asset Allocation Insight: This acquisition represents 1.02% of Neo Ivy's reportable assets in its 13F filing, reflecting a measured approach to diversify its portfolio while tapping into the momentum of healthcare real estate.
- Strong Stock Performance: As of February 12, 2026, shares of American Healthcare REIT were priced at $51.70, marking a 93.3% increase over the past year, which underscores the company's robust performance and growing market recognition among investors.
- Financial Metrics Improvement: The company reported a 16.4% same-store NOI growth in Q3, driven by a 25.3% increase in senior housing operating properties, indicating sustained demand and profitability in the healthcare real estate sector, while management raised full-year NFFO guidance, suggesting strong future growth potential.
See More
American Healthcare REIT Q4 2025 Earnings Call Insights
- Leadership Transition: Chairman and Interim CEO Jeffrey Hanson confirmed during the earnings call that despite the CEO's medical leave, the company's strategic direction and execution remain unchanged, ensuring investor confidence in future performance.
- Strong Financial Performance: In Q4 2025, AHR reported same-store NOI growth of 11.8% and 14.2% for the full year, demonstrating robust performance particularly in the Trilogy and SHOP segments, which further solidifies its market position.
- Active Investment Activity: The company closed over $950 million in new investments across its Trilogy and SHOP segments, with a focus on adding assets in attractive submarkets within SHOP, enhancing cash flow and portfolio diversification.
- Optimistic Outlook: Management issued 2026 NFFO guidance of $1.99 to $2.05 per diluted share, implying continued double-digit growth, while same-store NOI growth is expected to range between 7% and 11%, reflecting confidence in future growth prospects.
See More
American Healthcare REIT (AHR) Earnings Call
See More
American Healthcare REIT Issues 2026 Guidance Amid Q4 Results
- Financial Overview: American Healthcare REIT (AHR) reported Q4 FFO of $0.46, meeting expectations, while revenue of $604.08 million, up 11.3% year-over-year, fell short by $13.41 million, indicating revenue growth challenges.
- 2026 Performance Guidance: The company projects a midpoint net income per diluted share of $0.78 for 2026, ranging from $0.75 to $0.81, a significant increase from $0.42 in 2025, reflecting optimism about future profitability.
- NAREIT FFO Expectations: AHR anticipates a midpoint NAREIT FFO per diluted share of $1.96 for 2026, with a range of $1.93 to $1.99, compared to $1.76 in 2025, indicating improvements in cash flow management.
- Segment Growth Projections: The company expects total portfolio same-store NOI growth of 9.0% in 2026, with senior housing (SHOP) projected to grow by 17.0%, highlighting strong performance in specific market segments that could drive future growth.
See More
American Healthcare REIT Reports Strong 2025 Performance and 2026 Guidance
- Same-Store NOI Growth: The company reported an 11.8% Same-Store NOI growth for Q4 2025, with the SHOP segment leading at 24.6%, reflecting strong demand and supply fundamentals in the long-term care sector, which is expected to drive future revenue growth.
- Significant Acquisition Activity: In 2025, the company completed over $950 million in acquisitions, including approximately $370 million in the ISHC segment and $590 million in the SHOP segment, enhancing its asset portfolio and competitive positioning in the market.
- Capital Market Performance: As of December 31, 2025, the company had total debt of $1.54 billion and liquidity of approximately $1.14 billion, demonstrating strong financial flexibility and ongoing capital raising capabilities to support future expansion plans.
- 2026 Performance Guidance: The company anticipates Same-Store NOI growth for 2026 to range between 7% and 11%, with the SHOP segment expected to grow between 15% and 19%, which will provide continued earnings growth and returns for shareholders.
See More
American Healthcare REIT Executives to Participate in Citi Global Property CEO Conference
- Executive Participation: American Healthcare REIT's CFO Brian S. Peay, COO Gabe M. Willhite, and VP of Investor Relations & Finance Alan Peterson will participate in the Citi 2026 Global Property CEO Conference on March 4, 2026, showcasing the company's leadership in the healthcare real estate sector.
- Conference Timing: The roundtable discussion is scheduled from 8:10 to 8:45 a.m. Eastern Time, expected to attract significant attention from investors and industry experts, thereby enhancing the company's visibility in the market.
- Webcast Availability: The conference will be available via live webcast, allowing participants to watch in real-time through the provided link, with a replay available for one year post-conference, ensuring widespread dissemination of information.
- Company Background: American Healthcare REIT focuses on acquiring, owning, and operating a diversified portfolio of clinical healthcare real estate, primarily including senior housing communities, skilled nursing facilities, and outpatient medical buildings across the U.S., U.K., and the Isle of Man, demonstrating its strong foundation in the healthcare real estate market.
See More
Neo Ivy Capital Management Acquires Stake in American Healthcare REIT
- New Investment Position: Neo Ivy Capital Management disclosed in its February 13, 2026 SEC filing that it acquired 136,925 shares of American Healthcare REIT for approximately $6.44 million during Q4, indicating a strategic entry into the healthcare real estate market.
- Asset Allocation Insight: This acquisition represents 1.02% of Neo Ivy's reportable assets in its 13F filing, reflecting a measured approach to diversify its portfolio while tapping into the momentum of healthcare real estate.
- Strong Stock Performance: As of February 12, 2026, shares of American Healthcare REIT were priced at $51.70, marking a 93.3% increase over the past year, which underscores the company's robust performance and growing market recognition among investors.
- Financial Metrics Improvement: The company reported a 16.4% same-store NOI growth in Q3, driven by a 25.3% increase in senior housing operating properties, indicating sustained demand and profitability in the healthcare real estate sector, while management raised full-year NFFO guidance, suggesting strong future growth potential.
See More
